Loading...
The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens
Saved in:
| Published in: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100721/ https://ncbi.nlm.nih.gov/pubmed/33970156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-2020-15 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|